Viridian Therapeutics(VRDN) - 2019 Q2 - Earnings Call Transcript

miRagen Therapeutics, Inc. (MGEN) Q2 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Dan Ferry – Managing Director-LifeSci Advisors, LLC Bill Marshall – President and Chief Executive Officer Jason Leverone – Chief Financial Officer Conference Call Participants Liana Moussatos – Wedbush Securities Jonathan Miller – Evercore ISI Jennifer Grayson – R. W. Baird Leland Gershell – Oppenheimer Suji Jeong – Jefferies Operator Greetings and welcome to the miRagen Therapeutics’ Q2 2019 Ea ...